News that may have an impact on prices of some stocks today, 2nd July, 2025
By Prime Research | Published at: Jul 2, 2025 09:36 AM IST

RITES gets new order of Rs 30.3 crore from African Railway
Company received order worth US$ 3.6 million or Rs 30.3 crore from African Railway. It is to be executed in the next 9 months. RITES-Aryan Joint Venture has received the LoA from South Western Railway for Tumakuru Station Redevelopment Engineering, Procurement and Construction Agreement including Civil Works, Signal and Telecommunication works and Electrical General Services. RITES share stands at Rs 37.8 crore in the said JV. It is expected to complete in the next 18 months. The impact of this news on the stock price is likely to be positive.
Medi Assist subsidiary completes acquisition of Paramount Health
Medi Assist Insurance TPA Private Limited (Medi Assist TPA), a wholly owned subsidiary of Medi Assist Healthcare Services Limited announced the successful completion of its acquisition of a 100% stake in Paramount Health Services & Insurance TPA Pvt. Ltd. This acquisition marks a pivotal step in Medi Assist’s continued growth strategy, reinforcing its position as India’s largest health benefits administrator. With this transaction, Medi Assist is set to add Rs 4,000 crore of health premiums, under administration. The deal also enhances Medi Assist’s provider networks and enables the company to leverage operational synergies. Following the completion of the acquisition, both Medi Assist TPA and Paramount TPA will continue to operate independently until a formal merger process is completed. The impact of this news on the stock price of the company is likely to be positive.
Exicom Tele-systems to raise up to Rs 259.4 crore through rights issue
Board approved fund raising up to Rs 259.4 crore through rights issue. It would issue 1.81 crore equity shares at Rs 143 per share to eligible shareholders. The ratio has been fixed as three equity shares for every 20 shares held as on record date. Company has fixed July 07, 2025 as record date.
Coal India’s output down by 8.5% in June
Coal India’s coal production dropped by 8.5 per cent to 57.8 million tons (MT) in June even as the government aims to increase the output to reduce the dependency on imports. The coal production by the PSU was 63.1 MT in the corresponding month of the previous fiscal. • Coal India has partnered with Hindustan Copper to explore opportunities in the critical mineral sector, signing a non-binding MoU. This collaboration follows a similar agreement between CIL and IREL (India) Ltd, focusing on developing critical mineral assets like mineral sands and rare earth elements.
LTI Mindtree introduces GCC-as-a-Service
LTI Mindtree introduced its GCC-as-a-Service. The services cater to organizations that may want to set up GCCs, scale their existing ones to optimize costs and create added value. The catalogue covers a spectrum of Build, Operate, Transform and Transfer services, offering clients the option to pick and choose what they require.
JSW Renew Energy signs battery energy storage agreement with RVUNL
JSW Renew Energy Thirty Seven Ltd, a subsidiary of JSW Energy, has signed a Battery Energy Storage Purchase Agreement (BESPA) with Rajasthan Rajya Vidyut Utpadan Nigam Ltd (RVUNL) to establish a 250 MW/500 MWh standalone battery energy storage system (BESS).
Godrej Properties sells its 2.5% stake in Vivrut Developers
The company has announced the sale of its 2.5% stake in Vivrut Developers Pvt Ltd to Godrej Ventures and Investment Advisers Pvt Ltd for Rs 8.63 crore, under a newly executed share purchase agreement.
Nazara subsidiary completes acquisition of AFK Gaming
Nodwin Gaming, a subsidiary of Nazara Technologies, has completed the acquisition of a 92.3% stake in AFK Gaming Pvt Ltd. The deal, finalised through a share purchase agreement dated December 18, 2024, was valued at Rs 7.58 crore.
South Indian Bank’s gross advances increase by 8.02%
South Indian Bank’s gross advances stood at Rs 89,201 crore, reflecting an 8.02% year-on-year increase from Rs 82,580 crore as of June 30, 2024. Sequentially, gross advances rose from Rs 87,579 crore in the previous quarter. Total deposits reached Rs 1,12,922 crore, up 9.07% compared to Rs 1,03,532 crore a year earlier.
JSW Paints readying to become fourth-largest paint company in India
JSW Paints is preparing to become the fourth-largest paint company in India, following its planned acquisition of Akzo Nobel India. JSW Paints’ Managing Director, Parth Jindal, said that once they receive the necessary approvals, including from the CCI and after completing the open offer, the company will become the fourth-largest paint player in India. Looking at FY25 numbers combined, we would have a top line of about Rs 6,000 crore, and we would be in striking distance of the third largest player in the market.” Jindal added.
MOIL increases prices by 2%
MOIL has increased by 2% the prices of all ferro grades manganese ore with manganese content below 44%, at 44% and above 44% with effect from today, July 1.
CCI begins dominance abuse investigation against Asian Paints
India’s competition regulator launched a formal abuse of dominance investigation into Asian Paints following a complaint from Birla Opus Paints, a unit of Birla Group. The Competition Commission of India (CCI) found preliminarily evidence indicating that Asian Paints violated antitrust rules.
AstraZeneca gets approval for import of Durvalumab
AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab Solution for Infusion 120 mg/2.4 ml and 500 mg/10 ml (Brand name: Imfinzi) for an additional indication. Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab in combination with olaparib in endometrial cancer that is mismatch repair proficient (pMMR).
Maruti Suzuki’s sales in April-June period up by 1.1%
For April-June-2025 period, total sales grew 1.1% YoY at 5,27,861 units. Domestic sales declined 4.5% YoY at 4,30,889 units while exports sales increased 37% YoY at 96,972 units.
Paras subsidiary gets new order of Rs 22 crore
Paras Anti Drone Technologies Pvt Ltd, a subsidiary of Paras Defence and Space Technologies Ltd, has announced that France-based CERBAIR, intends to acquire up to 30 CHIMERA 200 systems (an advanced Man portable radio frequency detection and neutralization device) designed as primary defence against drone and swarm drone threats. The deal is worth approximately Rs 22 crore (€2.2 million) by Paras, strengthens India’s position as an emerging and reliable exporter of sophisticated defence technologies.
Hind Rectifiers got orders worth Rs 284 crore in June
Company received orders worth Rs 284 crore in June-2025. Total order book stood at Rs 1,025 crore as on July 01, 2025.
Zaggle Prepaid gets new contract
Zaggle Prepaid Ocean Services Limited (Zaggle), has entered into an agreement with DTDC Express Limited. Zaggle would provide DTDC Express Limited, Zaggle Zoyer & Zaggle Save (Employee expense management & benefits) propositions. It is for a period of five years.
Lupin carves out LupinLife as a wholly owned subsidiary
Lupin Limited announced the strategic carve-out of its consumer healthcare business, LupinLife Consumer Healthcare Ltd. (LCH), into a wholly owned subsidiary, effective July 1, 2025. This initiative aligns with the aspiration to establish a specialized consumer healthcare entity, with an enhanced focus on India’s rapidly growing self-care market. Since its inception in 2017, LupinLife Consumer Healthcare has emerged as a strong over-the-counter (OTC) healthcare business with a portfolio of scientifically formulated and trusted brands such as Softovac, Beplex Forte, Corcium and Aptivate. Anil Kaushal will lead the new independent entity as Chief Executive Officer. Lupin Limited received approval from the US FDA for its ANDA for Loteprednol Etabonate Ophthalmic Gel, 0.38%. Loteprednol Etabonate Ophthalmic Gel, 0.38% is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb Inc. Lupin is the exclusive first-tofile for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin’s Pithampur facility in India. It is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery. Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sales of US$ 29 million in the US (IQVIA MAT May 2025).
V-Mart’s revenues up by 13%
Total revenue from operations for the quarter stood at Rs 885 crore as compared to Rs 786 crore last year a year on year growth of 13%. SSSG stood at 1% for the quarter. Company has opened 15 new stores and closed 2 stores in the quarter. With this total stores stood at 510 as of June-2025.
India Pesticides commissions expansion of formulation plant
Company has successfully commissioned the expansion of formulation plant. The Company has increased the capacity by 3500 MT from the existing capacity of 6500 MT per annum with the total capacity will enhance to 10,000 MT per annum of formulation.
NIBE gets new purchase order of Rs 22.66 crore
Company has received a Purchase Order from one of the leading Infra and Defence Company for Supply of Turrets Structure Assembly for a total consideration of Rs 22.66 crore (inclusive of all taxes and duties).
CNL Energy gets new project
CNL Energy Limited (CLN) announced that it has received LithiumIon battery supply project for Bharat Sanchar Nigam Limited (BSNL). The first phase of the supply, scheduled for completion by June 2025, was successfully dispatched. CLN is now actively progressing with the second phase, which is on track for completion by the committed deadline of July 14, 2025. CLN successfully secured a tender valued at approximately Rs 107.9 crore (PO Order Rs 77 crore) to supply Lithium-Ion batteries. This win highlights the company’s technical capabilities and reinforces its commitment to supporting critical infrastructure with clean and reliable energy solutions.
Disclaimer : This content is only for informational purpose. It does not make any recommendation to act or invest. To get any error corrected, please write to content@hdfcsec.com.
Source: HDFC Securities Prime Research

